Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 10 Show results per page	View Search Criteria \| Help With Results


1.		Intron-A/Aldara Combination Therapy for Basal Cell Carcinoma (BCC)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Treatment				Active				Not specified				Other				HSC-MS-06-0478 OSP-24412, NCT00581425

Last Modified: 6/12/2008 First Published: 2/27/2008


2.		Phase I/II Randomized Study of Cytomegalovirus-Specific T-Cell Adoptive Transfer in Patients With Newly Diagnosed Glioblastoma Multiforme Who Are Recovering From Therapeutic Temozolomide-Induced Lymphopenia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Biomarker/Laboratory analysis, Diagnostic, Treatment				Active				18 and over				NCI				DUMC-PRO00000580 PRO00000580, DUMC-SPORE Project 3, NCT00627224

Last Modified: 6/16/2008 First Published: 3/13/2006


3.		Phase II Randomized Study of Adjuvant gp100 Peptide Immunization With or Without Montanide ISA 51 and/or Imiquimod in Patients With Resected High-Risk Melanoma (Treatment Arms I-IV Closed to Accrual as of 1/11/08)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				16 and over				NCI				NCI-06-C-0069 7676, NCI-7676, NCI-P6703, NCT00304057


4.		Study of Immune Responses to Influenza Vaccination With or Without Imiquimod Application in Untreated CLL Patients

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care				Active				Not specified				Other				Eudract number: 2006-004902-16 LREC number: 06/Q2201/143, NCT00596336


5.		Safety and Immunogenicity of CYT004-MelQbG10 Vaccine With and Without Adjuvant in Advanced Stage Melanoma Patients

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Pharmaceutical / Industry				CYT004-MelQbG10 04 NCT00651703

Last Modified: 5/2/2008 First Published: 3/22/2007


6.		Phase I Pilot Study of In Situ Photoimmunotherapy Comprising Imiquimod and Infrared Laser Therapy With or Without Indocyanine Green in Patients With Stage III or IV Melanoma and Cutaneous Metastases

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Biomarker/Laboratory analysis, Treatment				Active				18 to 100				Other				OU-12576 12576, OU-ISPI, NCT00453050


7.		Viral Load Determination and Biomarkers of High Risk HPV-Types in HIV-Positive Men

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Natural history/Epidemiology, Treatment				Active				18 and over				Other				01 KI 0211 NCT00365729


8.		A Pilot Study of the Treatment of Facial Nodular and Nodulocystic Basal Cell Carcinoma With Double Curettage and Cautery Followed by Application of Imiquimod to the Base

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Treatment				Approved-not yet active				49 to 89				Other				WN07DE002 EudraCT No: 2007-001961-14, NCT00463359

First Published: 7/13/2007


9.		Pilot Study of Topical Imiquimod Therapy in Patients With Recurrent Extramammary Paget's Disease of the Vulva

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Diagnostic, Treatment				Active				18 and over				NCI				MSKCC-07029 07-029, NCT00504023

First Published: 2/27/2008


10.		Pilot Study of Regulatory T-Cell Inhibition With Daclizumab During Antitumor Immunotherapy Targeted Against Cytomegalovirus in Patients With Newly Diagnosed Glioblastoma Multiforme and Therapeutic Temozolomide-Induced Lymphopenia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Diagnostic, Treatment				Active				18 and over				NCI				DUMC-PRO00000581 Pro00000581, SPORE Project 3, NCT00626483

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute